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Specific association of tissue transglutaminase (tTG)
with matrix fibronectin (FN) results in the formation of
an extracellular complex (tTG-FN) with distinct adhesive
and pro-survival characteristics. tTG-FN supports RGD-
independent cell adhesion of different cell types and the
formation of distinctive RhoA-dependent focal adhesions
following inhibition of integrin function by competitive
RGD peptides and function blocking anti-integrin anti-
bodies 51. Association of tTGwith its binding site on the
70-kDa amino-terminal FN fragment does not support this
cell adhesion process, which seems to involve the entire
FN molecule. RGD-independent cell adhesion to tTG-FN
does not require transamidating activity, is mediated by
the binding of tTG to cell-surface heparan sulfate chains,
is dependent on the function of protein kinase C, and
leads to activation of the cell survival focal adhesion
kinase. The tTG-FN complex can maintain cell viability
of tTG-null mouse dermal fibroblasts when apoptosis
is induced by inhibition of RGD-dependent adhesion
(anoikis), suggesting an extracellular survival role for
tTG. We propose a novel RGD-independent cell adhesion
mechanism that promotes cell survival when the anti-
apoptotic rolemediated byRGD-dependent integrin func-
tion is reduced as in tissue injury, which is consistent
with the externalization and binding of tTG to fibronectin
following cell damage/stress.
Subtle changes in the extracellular matrix (ECM)1 complex-
ity/tissue architecture may be crucial for the regulation of the
apoptotic machinery leading to anoikis (1, 2). Such a process
occurs during tissue injury when the composition and integrity
of the ECM are altered in several significant ways (3). A central
component of the ECM, which regulates adhesion-dependent
survival signaling, is the adhesive glycoprotein fibronectin
(FN) (4). FN binds to cell-surface matrix receptors, primarily
the 51 integrins, through the Arg-Gly-Asp (RGD) cell-binding
site within the Type III10 domain. The importance of the RGD
cell-binding domain in adhesion-mediated cell survival has
been demonstrated by employing synthetic peptides containing
the RGD motif, which induce apoptosis in many cell types, by
acting as competitive inhibitors of FN-integrin interaction and
activators of caspase 3 (5, 6). A comparable scenario may occur
in wounding and inflammatory conditions, whereby fragmen-
tation of FN can lead to detachment-induced apoptosis (5, 7).
However, the RGD cell-binding domain of FN is not sufficient
in isolation to regulate cell survival, which must be sustained
by other critical FN domains such as the C-terminal heparin-
binding domain (HepII) (7, 8), known to synergistically interact
with heparan sulfate proteoglycans (HSPG) receptors and in-
tegrin 41 (9). Evidence is also accumulating to suggest that
changes in the molecular structure and composition of the FN
matrix may provide new signals to regulate cell shape, migra-
tion, and proliferation. Alterations to the conformation of FN
either by multimerization (10) or heterotypic association with
other matrix molecules (11) could reveal biologically active
neo-epitopes, which regulate cell responses via the induction of
cytoskeleton assembly (12). Modulation of the FN matrix may
therefore also be fundamental in the regulation of adhesion-
related apoptosis.
One protein that binds with high affinity specialized FN
domains and modulates the function of FN is tissue-type trans-
glutaminase (tTG, TG-2) (10, 13, 14). tTG is a multifunctional
protein implicated in diverse normal and pathological pro-
cesses (15) but more specifically is regarded as an important
component of cell/tissue defense in response to cell damage and
stress (16, 17). tTG differs from the other transglutaminases in
that the transamidase active site is integrated with a GTP
binding/hydrolysis site, which negatively regulates the trans-
amidation activity by structurally blocking the active site (18).
Another peculiarity of tTG is its externalization into the ECM
via a non-Golgi/endoplasmic reticulum route, through a mech-
anism that appears to depend on its active-state conformation
(19) and an intact FN-binding site in the 28-kDa amino-termi-
nal sandwich region (20, 21). Matrix deposition of tTG in-
creases in situations of tissue damage and cellular stress and
results in the immobilization of tTG on matrix FN (16, 17, 20,
22), which in turn protects tTG from matrix degradation (23).
Consistent with these findings is the observation that guinea
pig liver tTG forms specific complexes with human plasma FN,
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and it appears as a globular protein bound to the N-terminal
portion of FN interacting either with the Type I4-I5 motif (24)
or with a sequence within the gelatin-binding domain of FN
(I6-II1-II2-I7-I8-I9) (13).
The involvement of tTG in the adhesion of multiple cell types
is now consolidated (25, 26); however, the molecular mecha-
nism and its physiological significance remain controversial. It
has been proposed that tTG enhances cell adhesion through
matrix remodeling, via protein cross-linking (10, 26); however,
recent findings suggest that tTG involvement in cell-matrix
interactions is independent from its transamidation activity
(19, 27, 28). Cell-surface tTG might act as an adhesion co-
receptor of integrins 1 and 3 by mediating cell adhesion to the
gelatin-binding domain of FN (27) or, conversely, act as an
independent adhesion protein by specific binding to 41 and
91 integrins (28).
In the current study we have explored the involvement of
tTG in FN-mediated cell survival, starting with the hypothesis
that the ECM function of tTG is strictly dependent on its
association with FN, and that tTG and FN reciprocally modu-
late each others functions following complex formation. We
report that FN-bound tTG supports a novel RGD-independent
cell adhesion process, which is mediated by the direct binding
of tTG to the cell surface through a mechanism that is critically
dependent on cell-surface heparan sulfate and activation of
protein kinase C (PKC). We describe that FN-bound tTG,
but not FN, can rescue tTG-deficient mouse dermal fibroblasts
from apoptosis induced by inhibition of RGD-dependent cell
adhesion (anoikis), with maintenance of cell viability. Our find-
ings suggest that matrix FN with bound tTG is functionally
distinct from either protein acting in isolation and suggest a
novel RGD-independent pathway that may be important in cell
survival under conditions of cell damage/stress.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies—Mouse monoclonal antibodies included
anti-integrin 1 (JB1A) and 5 (PID6) (Chemicon); vinculin and tubulin
(Sigma-Aldrich); and tTG (Cub74) (NeoMarkers). Rabbit polyclonal an-
tibodies included anti-human fibronectin (Sigma-Aldrich) and anti-hu-
man Tyr(p)397-FAK (Upstate Biotechnology). The tTG inhibitor R283
(19) was synthesized by R. Saint and I. Coutts, Nottingham Trent
University. Purified guinea pig liver tTG was either obtained by Sigma-
Aldrich or purified according to Leblanc et al. (29). Human plasma FN
and FN proteolytic fragments, GTP-S, and synthetic RGD-specific
peptides (GRGDTP and GRGDSP) were from Sigma-Aldrich and con-
trol RAD peptide (GRADSP) was from Calbiochem. Heparitinase
(EC4.2.2.8) was from Sigma-Aldrich, and chondroitinase ABC (pro-
tease-free) from Seikagaku Corporation. The PKC inhibitor GO6976
was from Calbiochem.
Cell Lines—Primary human osteoblasts (HOB) were provided by S.
Downes (University of Nottingham, Nottingham, UK) and maintained
in Dulbecco’s modified Eagle’s medium (DMEM) as we previously de-
scribed (30). Swiss 3T3 albino fibroblasts were obtained from American
Type Culture Collection and maintained in DMEM supplemented with
10% (v/v) fetal calf serum, 2 mM glutamine, and penicillin/streptomycin
(100 units/ml and 100 g/ml, respectively). Transfected Swiss 3T3
fibroblasts, displaying inducible expression of tTG (clone TG3), were
cultured and induced as described by Verderio et al. (22). Primary
mouse dermal fibroblasts (MDF) were isolated from the skin of tTG-
deficient (MDF-TG/) and wild type (MDF-TG/) 9-months-old
mice and maintained as described by De Laurenzi and Melino (31).
Immobilization of TG on FN and Amino-terminal FN Fragments—
96-well plates were coated with human plasma FN (5 g/ml) or with the
70 kDa (42 g/ml), 45 kDa (54 g/ml), and 30 kDa (54 g/ml) proteolytic
fragments of FN in 50 mM Tris-HCl, pH 7.4, 50 l/well, by incubation at
4 °C for15 h. Concentrations of FN and FN fragments were optimal to
saturate tissue culture plastic (TCP), as measured by an ELISA-based
assay with polyclonal anti-FN antibody (1/5000) followed by peroxidase-
labeled anti-rabbit IgG (1/5000). FN fragments were in a 30-, 60-, and
90-fold stoichiometric excess, respectively, of control FN. For tTG im-
mobilization, the FN solution was removed, the wells were washed once
in 50 mM Tris-HCl, pH 7.4, and then incubated with purified guinea pig
liver tTG (20 g/ml) in phosphate-buffered saline (PBS) containing 2
mM EDTA, 100 l/well. After 1 h at 37 °C, the tTG solution was removed
and wells were washed once in 50 mM Tris-HCl, pH 7.4, and once in
serum-free culture medium before cell seeding. In some experiments
FN-coated plates were blocked with 3% (w/v) lipid milk protein (Marvel)
in PBS at 37 °C for 30 min and then washed twice with 50 mM Tris-HCl,
pH 7.4, prior to tTG immobilization. The presence of tTG immobilized
on FN was confirmed by an ELISA-type assay using Cub74 as we
previously described (26). The transamidating activity of the immobi-
lized tTG was determined by the incorporation of biotinylated cadaver-
ine into FN as previously described (26) and compared with the activity
of free tTG standard. Data are expressed as absorbance 450 nm with 5
mM Ca2 in the reaction buffer minus background absorbance values
with 5 mM EDTA.
Cell Adhesion Assay—Exponentially growing cells were detached
using 0.25% (w/v) trypsin in 5 mM EDTA, collected into medium con-
taining a 7% (v/v) fetal calf serum, washed twice with medium with-
out fetal calf serum, and then plated onto 96-well plates (2  104
cells/well), coated with FN or FN fragments, with and without immo-
bilized tTG. After a maximum of 20 min incubation (to minimize the
secretion of any endogenous protein) at 37 °C in a 5% CO2 atmosphere,
cells were fixed in 3.7% (w/v) paraformaldehyde in PBS, permeabilized
in 0.1% (v/v) Triton X-100 in PBS, and stained with May Grunwald and
Giemsa stain (26). In some cases cells were pre-treated for 15 h with 1
mM cycloheximide before plating, to rule out any effects of endogenous
secreted adhesion molecules. Digital images of 3 non-overlapping fields
covering the central portion of each well were captured using a video
digital camera (Olympus DP10) and examined using the Image Analy-
sis program Scion Image (National Institute of Health). At least 9
images of separate fields per sample were examined for a total of at
least 400 cells in the FN control. The number of attached cell particles
in each field was measured by “thresholding” and “particle analysis”
and the spread cells by “density slicing.”
Cytoskeletal Staining—Actin stress fibers were visualized using flu-
orescein isothiocyanate (FITC)-labeled phalloidin and focal adhesions
by staining for vinculin. Cells were seeded in 0.79-cm2-wells of chamber
slides (8  104 cells/well) previously coated with FN and tTG-FN and
allowed to adhere for 20 min. Cells were fixed using 3.7% (w/v)
paraformaldehyde in PBS and permeabilized in 0.1% (v/v) Triton X-100
in PBS. For actin stress fibers, cells were then blocked in PBS buffer
supplemented with 5% (w/v) dry milk and then incubated with FITC-
labeled phalloidin (20 g/ml) in blocking buffer. For localization of
vinculin, cells were blocked in PBS buffer containing 3% (w/v) bovine
serum albumin and then incubated with mouse monoclonal anti-vincu-
lin antibody (1:100) in blocking buffer. Bound antibody was revealed by
incubation with rabbit anti-mouse IgG-FITC (1:100) (Dako) in blocking
buffer. Coverslips were mounted with Vectashield mountant containing
propidium iodide (Vector Laboratories) and examined by laser confocal
microscopy using a Leica TCSNT system (Leica Lasertechnik). Consec-
utive scanning sections (2 m) from the upper to the lower attach-
ment site of cells were overlaid as an extended focus image, and imaged
cells (from at least 8 random fields, at least 100 cells in FN control) were
scored for actin stress fiber formation with the aid of the Leica TCSNT
(version 1.5–451) image processing menu.
Inhibition of Integrin-mediated Cell Adhesion—Cells in suspension
(2  105 cells/ml) were incubated with GRGDTP synthetic peptide (32)
(50 g/ml, 75 M, 100 g/ml 150 M, or 200 g/ml 300 M). Some
experiments were reproduced using the FN-prototype GRGDSP pep-
tide. Alternatively, cells in suspension (2 105 cells/ml) were incubated
with function blocking anti-integrin antibodies (JB1A, 40 g/ml; and
P1D6, 30 g/ml). All incubations were performed in serum-free medium
at 37 °C for 10 min. Afterwards cells were seeded in the presence of
either the competitive RGD peptides or the anti-integrin antibodies.
Cell Treatment with C3 Exotranferase—Clostridium botulinum C3
exotransferase (Biomol) (20 g/ml) was incubated with LipofectAMINE
(100 g/ml) (Invitrogen) in DMEM at 22 °C for 1 h. After that the
complex was diluted 10 times in DMEM and added to duplicate 18-h-old
cell monolayers (80% confluent) in serum-free medium. After 2 h the
medium was removed, cells were allowed to recover for 30 min in
serum-containing DMEM, and then were seeded in 0.79-cm2-wells of
chamber slides (45  103 cells/well).
Quantification of Anoikis and Measurement of Cell Viability—For
fluorochrome labeling of DNA strand breaks, 6  105 cells were seeded
in duplicate in 9.6-cm2-wells pre-coated with FN or tTG-FN in the
presence or absence of RGD peptide. After 15 h incubation at 37 °C in
a 5% CO2 atmosphere, all cells (adhered and non-adhered) were col-
lected, washed twice in PBS, resuspended at the final concentration of
1.2  107 cells/ml, and fixed in suspension by addition of one volume of
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4% (w/v) paraformaldehyde in PBS. Cells were then permeabilized in
0.1% (v/v) Triton X-100 in 0.1% (w/v) sodium citrate buffer for 2 min on
ice (to minimize loss of fragmented DNA). Cells were labeled with
terminal deoxynucleotidyl transferase (TdT) and FITC-dUTP, using a
TUNEL kit according to the manufacturer’s instructions (Roche). The
fluorescence intensity was measured by flow cytometry using a Beck-
man Coulter EPICS XL. Cells were collected and data stored and
analyzed using the software SYSTEM II and WinMDI2.8. DNA frag-
mentation was also detected by in situ analysis of nuclei following
TUNEL, by confocal fluorescent microscopy. Cells found in suspension
were fixed and labeled in triplicate on 0.79-cm2-wells of glass slides
(5  104 cells/well). For quantification, the Leica confocal software
was used to acquire 3 random images per well for a total of 9 images per
experimental sample using a fixed protocol (with constant photo-mul-
tiplier tube and section-depth setting). Data are expressed as mean
number of apoptotic cells per well. Cell viability was assessed by a
colorimetric assay based on the metabolism of the tetrazolium salt XTT
(Roche), after an incubation period of 4 h with XTT. Data are expressed
as absorbance values at 492 nm after subtraction of values at 690 nm.
Statistics—Data are expressed as mean  S.D. and represent one of
at least 3 separate experiments undertaken in triplicate, unless stated
otherwise. Differences between data sets were determined by the Stu-
dent’s t test (two-tailed distribution, two-sample equal variance). Dif-
ferences described as significant in the text correspond to p  0.05.
RESULTS
Tissue Transglutaminase Bound to FN Supports RGD-inde-
pendent Cell Adhesion of Different Cell Types—Previous work
using fluorescent microscopy and immunogold electron micros-
copy demonstrated a close association of tTG with FN at the
cell surface/pericellular matrix (20, 22), consistent with the in
vitro-specific binding of the enzyme with human plasma FN
(13, 24). To investigate how tTG in complex with FN affects FN
cell adhesion, we first bound purified guinea pig liver tTG to
human plasma FN coated onto tissue culture plastic (TCP).
EDTA was included in the reaction to inhibit tTG transami-
dating activity. Measurement of binding by an ELISA-type
assay showed that FN, immobilized at the saturating concen-
tration of 5 g/ml, bound a saturating amount of tTG when
incubated with 20 g/ml free tTG (Fig. 1A). Using this initial
matrix model of immobilized FN with bound tTG (tTG-FN), the
contribution tTG to FN cell adhesion was examined by inhib-
iting integrin-mediated RGD-dependent cell adhesion with
competitive concentrations of soluble RGD peptides. HOBs
were selected as the initial cell model because they preferen-
tially adhere on FN in vitro, demonstrate an enhanced spread
morphology on biomaterials coated with tTG-FN (33), and are
characterized by a well defined pattern of integrin cell-surface
receptors, consisting mainly of RGD-binding 1 subunit paired
with 1, 2, 3, 5, and V subunits (34). In the absence of RGD
peptide, attachment to tTG-FN was comparable with FN (Fig.
1B, upper panel), although cell spreading appeared to be en-
hanced on tTG-FN (Fig. 1B, lower panel). At 50 and 100 g/ml
RGD peptide, attachment on FN was significantly reduced
(typically to 30–50% of control values on FN) (Fig. 1B, upper
panel), but attachment to tTG-FN was not significantly inhib-
ited at these same RGD peptide concentrations. Cell attach-
ment to tTG-FN in the presence of 100 g/ml RGD peptide was
85–95% of control cell attachment to FN without RGD peptide.
Only at 200 g/ml was cell attachment to tTG-FN significantly
lower in comparison to control FN without RGD peptide. At
FIG. 1. tTG bound to FN but not tissue culture plastic supports
RGD-independent cell adhesion. A, relative levels of tTG bound to
coated FN at increasing concentrations of free tTG. Data are expressed
as mean  S.D. absorbance at 450 nm and represent one typical exper-
iment undertaken in triplicate. Background absorbance (in the range of
0.02–0.15) was subtracted from data. The level of tTG bound to fi-
bronectin (FN) after incubation with 20 g/ml free tTG is significantly
different from the level after incubation with 10 g/ml, but not 30–50
g/ml tTG. The level of tTG bound to tissue culture plastic (TCP)
represents the positive experimental control. B, RGD-independent cell
adhesion of HOB cells and Swiss 3T3 fibroblasts (C) in response to
tTG-FN. Cell attachment (upper graphs in B and C) and cell spreading
(lower graphs in B and C) on FN and tTG-FN were assessed 20 min
after seeding cells pre-incubated with increasing concentrations of RGD
synthetic peptide (0–200 g/ml) (RGD 0–200), as described under “Ex-
perimental Procedures.” Insets in B and C show cell attachment (upper
insets) and spreading (lower insets) on FN when cells were pre-incu-
bated with equivalent concentrations of control RAD peptide (RAD
0–200). Each point represents the mean number of attached cells (cell
attachment) or the mean percentage of spread cells (cell spreading) 
S.D. Data are expressed as percentage of control values on FN, which
represents 100% and represent one of at least 3 separate experiments
performed in triplicate. Mean attachment values  S.D. on FN control
were 306  53 (HOB) and 166  3 (Swiss 3T3) in upper graphs, 246 
13 (HOB) and 155  14 (Swiss 3T3) in upper insets; mean percentage
values of spread cells on FN control were 78  5 (HOB) and 88  1
(Swiss 3T3) in lower graphs and 82  2 (HOB) and 86  3 (Swiss 3T3)
in lower insets; total cells analyzed in control sample were 900 (HOB)
and 500 (Swiss 3T3). D, comparison of HOB cell attachment to TCP
with increasing concentrations of bound tTG (20–50 g/ml) and TCP
with bound FN (5 g/ml) in complex with tTG (20–50 g/ml). Cell
attachment was assessed and expressed as described above (RGD pep-
tide was 100 g/ml). Mean attachment values  S.D. on FN control
were 214  22. Total cells analyzed in control sample were 700.
RGD-independent cell attachment to TCP with bound tTG did not
significantly differ from cell attachment to TCP at any tTG
concentration.
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this higher concentration, the RGD peptide may in part act
nonspecifically, because the control RAD peptide also led to a
small reduction in cell attachment at 200 g/ml (Fig. 1B, upper
inset). Incubation of cells with RGD peptide significantly re-
duced cell spreading on FN (Fig. 1B, lower panel), typically to
10–50% of control value at 100 g/ml RGD peptide, but as for
cell attachment, cell spreading was only partially reduced on
tTG-FN at 50 and 100 g/ml RGD peptide (usually to 65–85%
of control values on FN). Swiss 3T3 fibroblasts displayed a
comparable response to HOB cells on the tTG-FN complex.
Attachment (Fig. 1C, upper panel) and spreading (Fig. 1C,
lower panel) of Swiss 3T3 fibroblasts to FN was significantly
decreased with excess RGD peptide, in a more sensitive way
than in osteoblasts (typically to 25–35% of control at 100 g/ml
RGD peptide), but was restored to control levels when cells
were seeded onto tTG-FN at 50 and 100 g/ml RGD peptide. An
epithelial-like cell line (ECV304) also adhered more efficiently
on tTG-FN than FN in the presence of excess RGD peptide (Fig.
Suppl. 1). When cells were seeded onto TCP coated with tTG
without prior immobilization of FN, cell attachment was found
to be negligible at concentrations ranging from 20 to 50 g/ml
of tTG, in the absence or presence of competitive RGD peptide
(Fig. 1C). Plates were coated with saturating amounts of FN,
and blocking of FN-coated wells with 3% nonfat milk protein
prior to tTG immobilization did not affect RGD-independent
cell attachment and spreading supported by the tTG-FN ma-
trix formed in the absence of blocking (data not shown). These
findings clearly indicate that the complex of tTG bound to FN
is the essential component for the RGD-independent cell adhe-
sion to occur. Association of purified tTG to free human plasma
FN in solution prior to immobilization onto TCP, with the
suggested stoichiometry of 2:1 (24), also led to a matrix able
to significantly support RGD-independent cell adhesion and
spreading (which respectively were 80  1.4 and 98  3.9 of
control FN, in a typical experiment with 100 g/ml RGD pep-
tide). Cells pre-treated with cycloheximide, to rule out secretion
of endogenous adhesion molecules, were still capable of RGD-
independent cell attachment on tTG-FN (data not shown). To-
gether these data show that binding of tTG to FN supports a
novel RGD-independent pathway.
tTG Immobilization on Amino-terminal FN Fragments Is Not
Sufficient to Mediate RGD-independent Adhesion of Osteoblast-
like Cells—Because tTG is known to bind to FN at a domain
within the 70 kDa amino-terminal fragment (13, 24) we ex-
plored whether association of tTG to N-terminal FN peptides
was sufficient to support RGD-independent cell adhesion. tTG
was immobilized on the 70 kDa (matrix assembly, heparin and
gelatin binding), 45 kDa (gelatin binding) and 30 kDa (first
type I repeats, matrix assembly, heparin binding) amino-ter-
minal FN peptides. Detection of the relative levels of tTG by
ELISA showed that incubation of the FN fragments with 20
g/ml tTG resulted in saturating levels of tTG immobilized on
all fragments (Fig. 2A). Cell adhesion of HOB cells to the
different FN fragments alone or in complex with tTG was
compared. On the 70 kDa fragment alone, both cell attachment
and spreading in the absence of RGD peptide were 80% the
values obtained on FN (Fig. 2B, upper and lower panels, re-
spectively); however, on the 45 kDa and 30 kDa fragments cell
attachment and cell spreading were only 10 and 5% of
control FN, respectively. In the presence of RGD peptide, cell
attachment and spreading values on the 70 kDa fragment were
significantly inhibited by 40% (Fig. 2B, upper and lower pan-
els, respectively). This data agrees with previous findings that
the amino-terminal of FN binds the integrin 51 in cross-
competition with the RGD peptide (12). Immobilization of tTG
on the 70 kDa fragment unlike FN did not induce RGD-inde-
pendent cell attachment and spreading but led to further de-
terioration of cell adhesion (Fig. 2B). Yet tTG did not enhance
cell adhesion to the 70-kDa fragment even in the absence of the
RGD peptide. Furthermore, tTG did not improve cell adhesion
on the 45-kDa and 30-kDa fragments, which remained at neg-
ligible levels (Fig. 2B). These results indicate that adhesion of
HOB cells to the amino-terminal 45 kDa and 30 kDa FN frag-
ments, which contain putative tTG-binding sites (13, 24), is
FIG. 2. tTG immobilization on amino-terminal FN fragments is
not sufficient to mediate RGD-independent cell adhesion. A,
relative levels of tTG bound to the amino-terminal FN fragments (70,
45, and 30 kDa) immobilized on TCP, at increasing concentrations of
free tTG. Data are expressed as mean S.D. absorbance at 450 nm and
are from a typical experiment performed in triplicate. The level of tTG
bound to each fragment after incubation with 20 g/ml tTG was not
significantly different from the level bound using 30 g/ml. B, assess-
ment of cell adhesion in response to tTG bound to amino-terminal FN
fragments. Wells were pre-coated with amino-terminal FN fragments,
and in half of the wells 20 g/ml tTG was immobilized upon them
(TG-70, TG-45, and TG-30). Cell attachment (B, upper panel) and cell
spreading (B, lower panel) of HOB cells pre-incubated with RGD pep-
tide (100 g/ml) (RGD) or DMEM (RGD) were assessed and data
expressed as described in legend to Fig. 1. In B, upper panel, ordinate
represents mean cell attachment expressed as mean percentage of
control attachment to FN (which represents 100%)  S.D. of 3 inde-
pendent experiments undertaken in triplicate (mean attachment
value  S.D. on FN in the 3 experiments was 406  72, 370  49, and
465  51; total cells analyzed in control samples were respectively
1200, 1100, and 1400). In B, lower panel, ordinate represents the
mean percentage of spread cells, expressed as mean percentage of
control spreading on FN  S.D. of 3 independent experiments under-
taken in triplicate (mean percentage of spreading  S.D. on FN in the
3 experiment was 87  1, 91  1, and 88  7).
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negligible regardless of the binding of tTG, and that tTG bind-
ing to the 70-kDa peptide is not sufficient to sustain RGD-
independent cell adhesion.
RGD-independent Cell Adhesion to FNwith Immobilized tTG
Promotes Formation of Unique Focal Adhesion Structures—
Formation of actin stress fibers in the presence of integrin-
binding RGD peptide in response to tTG-FN was analyzed by
confocal laser scanning microscopy utilizing FITC-phalloidin.
HOB cells adhered to FN did not show organized stress fibers
following RGD peptide treatment (Fig. 3A, panel c), compared
with non-treated cells (Fig. 3A, panel a), which exhibited a flat
morphology and extensive actin stress fibers. In contrast, most
of the cells seeded on tTG-FN were spread and had organized
actin stress fibers despite the RGD peptide (Fig. 3A, panel d);
however, the actin fibers formed were shorter and less orga-
nized than those assembled in control cells adhered to FN in
the absence of RGD peptide (Fig. 3A, panel a). Without RGD
peptide, actin stress fibers appeared more dense and well
formed in response to tTG-FN than FN (Fig. 3A, panels b and
a, respectively), confirming that immobilized tTG enhances cell
spreading (see Fig. 1B). Staining for vinculin indicated the
absence of punctate characteristic focal contacts of FN-adhered
cells (Fig. 3A, panel e) in the RGD-treated cells adhered to FN
(Fig. 3A, panel g) but not in those adhered to tTG-FN (Fig. 3A,
panel h). Relative measurement of the formed actin stress
fibers (Fig. 3A, graph) confirmed that the RGD peptide did not
affect the formation of focal adhesions in cells plated on tTG-
FN, although it significantly affected the quality of the actin
reorganization, as shown by fluorescence microscopy (Fig. 3A,
panel d). Treatment of cells with the function blocking anti-
integrin 1 (JBIA) and, to a lesser extent, 5 antibody (PID6),
led to a large decrease of actin stress fibers on FN (Fig. 3B,
panels b and c, respectively), compared with cells incubated
with nonspecific IgG (Fig. 3B, panel a). In contrast, on tTG-FN,
cells incubated with the anti-integrin antibodies appeared to
maintain a network of actin stress fibers (Fig. 3B, panels e and
f), although less elaborated and dense than in control cells
treated with IgGs (Fig. 3B, panel d). Comparison of the number
of formed actin stress fibers (Fig. 3B, graph) statistically con-
firmed these observations that tTG-FN leads to the formation
of integrin 1- and 5-independent actin filaments even though
more rudimental than in the absence of inhibition. RGD-inde-
FIG. 3. Confocal laser fluorescence
microscopy of RGD-independent ac-
tin cytoskeleton organization and fo-
cal adhesion in response to tTG-FN.
A, visualization of actin stress fibers and
focal adhesions in the presence of RGD
peptide. Cells were seeded as in legend to
Fig. 1 and the indicated cells pre-treated
with RGD peptide (100 g/ml) (RGD). Ac-
tin stress fibers and focal adhesions were
revealed as described under “Experimen-
tal Procedures.” Images were acquired by
confocal laser fluorescence microscopy,
and cells in random fields (at least 100
cells in FN control) were scored for actin
stress fiber formation as outlined under
“Experimental Procedures.” Data shown
in the histogram are from a representa-
tive experiment. Ordinate represents the
mean percentage of cells with formed ac-
tin stress fibers expressed as percentage
of control values on FN. Mean  S.D.
percentage of cells with stress fibers
formed on control FN was 74  2. Arrows
point to tTG-FN-mediated stress fibers
with and without RGD peptide. Bars 10
M. B, actin stress fibers in the presence
of function blocking anti-integrin 5 and
1 antibodies. HOB cells in suspension
were pre-incubated with anti-integrin an-
tibodies P1D6 (5) and JB1A (1) or con-
trol mouse IgGs (IgG) before seeding on
either FN or tTG-FN as described in A. At
least 200 cells in FN/IgG control were
scored. Mean percentage value of cells
with actin fibers formed on control FN 
S.D. was 49  8.4 in B, upper panel, and
53  7.8 in B, lower graph. Bars  10 M.
C, relative measurement of actin stress
fibers following pre-incubation with the
RhoA inhibitor C3 exotransferase. Mono-
layers of HOB cells were loaded with C3
exotransferase (C3), or Lipofectin only
(Lpf), as described under “Experimental
Procedures” and then seeded as described
in A. At least 250 cells in FN/Lpf control
were scored. Mean percentage value of
cells with actin fibers formed on control
FN  S.D. was 63  5.
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pendent adhesion of cells to tTG-FN was dependent on GTPase
RhoA, because inhibition of RhoA activity by botulinum toxin
C3 exotransferase almost completely blocked RGD-independ-
ent assembly of actin stress fibers in response to tTG-FN
(Fig. 3C).
tTG Cross-linking Activity Is Not Required to Support RGD-
independent Cell Adhesion—We next assayed the transamidat-
ing activity of FN-bound tTG to establish its potential role in
the described RGD-independent cell adhesion process. The ac-
tivity of tTG once bound to FN was negligible when measured
in cell culture medium DMEM, which contains an activating
concentration of Ca2 (1.9 mM), and was not changed by addi-
tion of further Ca2, but was significantly boosted by pre-
incubation of tTG with DTT prior to immobilization on FN (Fig.
4A), as described previously (26). Hence, under the conditions
used FN-bound tTG is not active in the presence of cell culture
medium, unless its cysteine residues, particularly the active-
site Cys277, are kept in a reduced state. The transamidation-
independent role of tTG in the RGD-independent cell adhesion
process was further confirmed by utilizing the irreversible in-
hibitor R283, a 2-[(2-oxopropyl)thio]imidazolium derivative
(19). HOB cells were incubated with R283 and plated on a
tTG-FN matrix pre-treated with R283, in the absence or pres-
ence of RGD peptide. Under these conditions the activity of the
immobilized tTG is completely blocked by the inhibitor (Fig.
4C). The low tTG activity found at the HOB cell surface (30) is
also inhibited to negligible values by equal concentrations of
R283.2 Cell adhesion on FN bound to inactivated tTG was not
significantly different from cell adhesion on FN bound to tTG
not treated with the inhibitor, with or without pre-treatment of
cells with RGD peptide, and it was typically twice cell adhesion
on FN in the presence of RGD peptide (Fig. 4B, cell attachment,
upper panel; cell spreading, lower panel). These data clearly
indicate that FN-bound tTG does not require its transamidat-
ing activity to promote RGD-independent cell adhesion.
Evidence for the Importance of FN-associated tTG and its
Calcium-induced Conformation in Cell-surface Recogni-
tion—To assess the importance of tTG in cell-surface interac-
tion, FN-bound tTG was blocked by using the monoclonal anti-
tTG antibody Cub74 in conditions that fully preserved the
availability of FN in this complex. This was demonstrated by
the unchanged recognition of FN by anti-FN polyclonal anti-
body after treatment of tTG-FN with either Cub74 or control
IgG (Fig. 5B). Obstruction of tTG by Cub74 completely abol-
ished the RGD-independent cell adhesion mediated by tTG-FN
(Fig. 5A, cell attachment, upper panel; cell spreading, lower
panel), suggesting a direct role for FN-associated tTG in the
RGD-independent binding to cells. tTG can assume two confor-
mations, depending on whether it is bound to GTP/GDP or
Ca2 (18). In the extracellular environment, tTG is likely to
assume the Ca2-induced open structure. Incubation of FN-
bound tTG with the non-hydrolysable GTP-S (1 mM) signifi-
cantly reduced the RGD-independent cell attachment and
spreading mediated by tTG-FN (Fig. 5C, upper and lower pan-
els, respectively). Because incubation of tTG with GTP-S did
not significantly alter the level of tTG bound to FN (Fig. 5D),
our results suggest that RGD-independent cell adhesion to
tTG-FN critically depends on the calcium-mediated tertiary
structure of tTG.
Role of Cell-surface Heparan Sulfate in RGD-independent
Cell Adhesion and Signaling via tTG-FN—To explore the pos-
sibility that cell adhesion to tTG-FN may be mediated by a
cell-surface proteoglycan, HOB cells were treated with glyco-
saminoglycan-degrading enzymes. Degradation of cell-surface
heparan sulfate chains with heparitinase (15 milliunits/ml) led
to a reduced cell attachment to FN (70% of control values)
(Fig. 6A, upper panel), as expected given the importance of
cell-membrane HSPG in the adhesion of osteoblast-like cells
(34). It also led to complete abolishment of RGD-independent
cell attachment and spreading on tTG-FN (Fig. 6A, upper and
lower panels, respectively). In contrast, equal concentrations of
protease-free chondroitinase ABC had no significant effect on
cell adhesion to FN, did not significantly alter RGD-independ-2 D. Telci, E. A. M. Verderio, and M. Griffin, unpublished data.
FIG. 4. tTG cross-linking activity is not required to support
RGD-independent cell adhesion to tTG-FN. A, the activity of FN-
bound tTG (TG-FN) was measured by incorporation of biotinylated
cadaverine into FN in either culture medium DMEM (DM), or DMEM
with 5 mM Ca2 (DM-Ca2), or DMEM supplemented with 5 mM DTT
(DM-DTT). Values represent the mean  S.D. absorbance at 450 nm of
one typical experiment undertaken in triplicate. B, cell adhesion to
tTG-FN following inactivation of tTG. The tTG-FN matrix was incu-
bated with the tTG irreversible inhibitor R283 (100 M) and then
utilized as adhesive substrate for HOB cells, further supplemented with
the same concentration of R283. In controls, identically treated cells
were seeded on tTG-FN without R283 treatment. Where indicated, cells
were pre-incubated with RGD peptide (100 g/ml). Cells were examined
for cell attachment (B, upper panel) and cell spreading (B, lower panel)
and data expressed as percentage of control values on FN as in the
legend to Fig. 1. Mean attachment value on FN control S.D., 373 36
in B, upper panel; mean percentage value of spread cells  S.D. on FN
control, 89  6 in B, lower panel; total cells analyzed in control sample,
1100. Data shown are from a representative experiment undertaken
in triplicate. C, inhibition of the cross-linking activity of FN-bound tTG
(TG-FN) and tTG-free in solution (fTG) by 100 M R283, when meas-
ured as described in A, in buffer containing DTT. Values represent the
mean  S.D. of a representative experiment undertaken in triplicate.
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ent cell spreading on tTG-FN (Fig. 6A, lower panel), and only
marginally affected cell attachment (Fig. 6A, upper panel).
These results demonstrate that RGD-independent cell adhe-
sion to tTG-FN critically depends on cell-surface heparan sul-
fate and suggest the involvement of cell-surface HSPG and not
chondroitin sulfate proteoglycans in this process. Syndecan-4 is
the only known HSPG that is a widespread component of focal
adhesions, and downstream signaling specifically involves
PKC (35). Cells were therefore treated with the selective
PKC inhibitor G06976 (36) prior to and during the cell adhe-
sion experiments. Following G06976 incubation, a significant
inhibition (30%) of both attachment and spreading on FN
(Fig. 6B, upper and lower panels, respectively) with control
RAD and RGD peptide occurred, which was comparable with
the inhibition of attachment following heparitinase (Fig. 6A,
upper panel). However, the PKC inhibitor drastically reduced
FIG. 5. RGD-independent cell adhesion to FN-bound tTG de-
pends on tTG accessibility and GTP-mediated conformational
change. A, FN-bound tTG was blocked by incubation with Cub74 (40
g/ml) for 1 h at 37 °C in PBS with 2 mM EDTA using mouse IgG1k as
control antibody. Following pre-incubation with RGD peptide, cells
were seeded on the tTG-FN matrix. Adhered cells were examined for
cell attachment (A, upper panel) and cell spreading (A, lower panel) and
data expressed as in the legend to Fig. 1. Mean attachment value S.D.
on FN control, 229  13 in A, upper panel; mean percentage value of
spread cells  S.D. on FN control, 93  2 in A, lower panel; total cells
analyzed in control sample, 700. Data are from a typical experiment
undertaken in triplicate. B, availability of FN, detected as described
under “Experimental Procedures,” after blocking the tTG-FN matrix by
Cub74 and IgG1k. Values represent the mean S.D. absorbance at 450
nm of 4 replicates from a typical experiment. C, HOB cells in suspen-
sion, pre-incubated with RGD peptide (100 g/ml) as indicated, were
seeded in the presence of 1 mM GTP-S on FN-bound tTG, pre-incu-
bated with 1 mM GTP-S in PBS for 10 min at room temperature.
Adhered cells were examined for cell attachment (C, upper panel) and
cell spreading (C, lower panel) with and without inactivation of tTG by
GTP-S and data expressed as in the legend to Fig. 1. Mean attachment
value  S.D. on FN control, 294  98.32 in C, upper panel; mean
percentage value of spread cells  S.D. on FN control, 84.9  4 in C,
lower panel; total cells analyzed in control sample, 800. Data are from
a typical experiment undertaken in triplicate. D, relative levels of tTG
that bind FN in the presence of 1 mM GTP-S, in conditions identical to
C above. tTG was detected by an ELISA-type assay described in the
“Experimental Procedures.” Values represent the mean  S.D. absorb-
ance at 450 nm of 4 replicates from a representative experiment.
FIG. 6. RGD-independent cell adhesion to tTG-FN is depend-
ent on cell surface heparan sulfate and PKC activity. A, HOB
cells in suspension (2  105 cell/ml) were pre-treated with 15 milli-
units/ml heparitinase or 15 milliunits/ml protease-free chondroitinase
ABC in serum-free medium for 1 h at 37 °C before evaluating cell
attachment (upper panel) and cell spreading (lower panel) in the pres-
ence of RGD or RAD peptide (100 g/ml). Data are produced and
expressed as in the legend to Fig. 1 and represent percentage of control
values on FN from one of 3 separate experiments. Mean attachment
values  S.D. on FN control without peptide treatment (not shown),
140  16; mean percentage values of spread cells on FN control, 89 
2; total cells analyzed in control sample, 420. B, monolayers of sub-
confluent HOB cells were serum-starved for 12 h and then incubated in
serum-free DMEM medium supplemented with the PKC inhibitor
Go¨6976 (5 M, dissolved in Me2SO) for 1 h or with an equal volume of
Me2SO only. Cells were then harvested and analyzed for cell attach-
ment (upper panel) and spreading (lower panel) on FN and tTG-FN.
Data, expressed as percentage of control values on FN, are from one of
3 separate experiments. Mean attachment and spread cell values 
S.D. on FN control without peptide (not shown), 197  8 and 83  4,
respectively; total cells analyzed in control sample, 590.
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RGD-independent attachment (over 90%) and spreading
(85%) mediated by the tTG-FN complex (Fig. 6B), indicating
that cell adhesion mediated by tTG-FN critically depends on
PKC activity. This finding also hints at syndecan-4 as the
likely HSPG responsible for binding the tTG-FN complex.
RGD-independent Adhesion in Response to tTG-FN En-
hances Tyrosine Phosphorylation of FAK—Having shown that
tTG-FN transmits signals via a heparan sulfate receptor lead-
ing to cell spreading and that this process depends on the
activity of PKC, we next examined whether the attachment to
tTG-FN led to activation of FAK. Tyrosine phosphorylation of
FAK in cells plated on FN and treated with RGD peptide was
decreased to 25% of that found in control cells plated on FN
and pre-incubated with control RAD peptide (Fig. 7). In re-
sponse to tTG-FN instead, the level of FAK phosphorylation in
the presence of RGD peptide was found to be 60% of the level
of both control cells on FN or tTG-FN. This data shows that the
RGD-independent cell adhesion mediated by tTG-FN enhances
tyrosine phosphorylation of FAK and as such implies FAK as
one of the intracellular signaling mediators of tTG-FN.
RGD-independent Cell Adhesion Can be Mediated by a Phys-
iological Matrix of Cell-assembled FN and Cell-secreted
tTG—We have previously shown (19, 20, 22, 37) that increased
expression of tTG within cells results in an increased export of
the enzyme into the extracellular matrix. Such a phenomenon
has been observed during cell stress and following cell wound-
ing (16, 17). To produce such a cell model, conditioned matrices
of cell-assembled FNwith different bound levels of cell-secreted
tTG were obtained from a long-term culture of a transfected
fibroblast cell line (Swiss 3T3-TG3), capable of tetracycline (tet)
regulatable expression of tTG (22). Cells were then removed
from both conditioned matrices, and in their place wild-type
Swiss 3T3 fibroblasts were seeded and allowed to adhere in the
presence of increasing concentrations of RGD peptide. The
FN-rich ECM with increased amounts of cell-secreted tTG
(ECM/TG3-tet) (Fig. 8B) supported significantly higher RGD-
independent cell attachment at each RGD peptide concentra-
tion, compared with the ECM with background levels of tTG
(ECM/TG3tet) (Fig. 8A). RGD-independent cell attachment
on the lower tTG containing ECM/TG3tet could be signifi-
cantly increased by immobilization of purified tTG on this
matrix (ECM/TG3tet plus tTG) (Fig. 8A). However, at low
levels of RGD peptide, cell attachment was still more effective
on the ECM containing cell-secreted tTG (ECM/TG3-tet) than
on the ECM containing added tTG (ECM/tTG3tet plus tTG).
This was despite higher levels of tTG present following exoge-
nous addition of TG (data not shown), suggesting that cell-
secreted tTG is better presented to the cell surface. The ECM
deposited by cells with increased levels of tTG (ECM/TG3-tet)
showed no significant difference in tTG enzymatic activity
above background (ECM/TG3tet) in culture medium, unless
in the presence of reducing agent (Fig. 8C). This is consistent
with the idea that tTG activity is gradually down-regulated
once sequestered in the oxidizing extracellular environment.
FN-bound tTG Rescues Primary Dermal Fibroblasts from
Anoikis—A potential physiological function of the tTG-medi-
ated RGD-independent cell adhesion is the protection from
apoptosis (anoikis) triggered by inhibition of RGD-dependent
adhesion. This phenomenon could occur in tissue injury when
changes in the ECM composition lead to reduction of RGD-de-
FIG. 7. RGD-independent adhesion to tTG-FN promotes tyro-
sine phosphorylation of FAK. Lysates of HOB cells grown in the
presence of RGD or RAD control peptide (100 g/ml) on FN, tTG-FN, or
control bovine serum albumin-coated TCP, were Western blotted and
then immunoprobed with Tyr(p)397-FAK antibody followed by peroxi-
dase conjugate anti-rabbit IgG (FAK-PY), as described under “Experi-
mental Procedures.” After stripping, blots were re-probed to reveal
control protein tubulin (Tub). Density of bands was quantified by scan-
ning densitometry, and phospho-FAK bands normalized against values
for tubulin bands (relative FAK-PY). Results from one of three typical
experiments are shown.
FIG. 8. A physiological matrix of FN and cell-secreted tTG
supports RGD-independent cell adhesion of Swiss 3T3 fibro-
blasts. A, Swiss 3T3-TG3 cells were grown on TCP either in the absence
of tet, to induce the expression of tTG and deposit an ECM rich in tTG
(ECM/TG3tet), or in the presence of tet, to inhibit tTG overexpression
and deposit a ECM with background levels of tTG (ECM/TG3tet).
Cells were then removed by 5 mM EDTA in PBS, and the remaining
matrices used to measure the attachment of wild-type Swiss 3T3 fibro-
blasts, pre-incubated with increasing concentrations of RGD peptide
(30–100 g/ml). RGD-independent adhesion was also tested on ECM/
TG3tet supplemented with purified tTG (20 g/ml), which was immo-
bilized as done on purified FN (ECM/TG3tet plus TG). Each point
represents the mean number of attached cells S.D. of a representative
experiment performed in triplicate. B, relative levels of tTG in the ECM
of cells overexpressing tTG (TG3tet) and with background tTG
(TG3tet). tTG was detected by an ELISA-type assay described under
“Experimental Procedures.” Values represent the mean  S.D. of 6
replicates from a representative experiment. C, cross-linking activity of
tTG in ECM/TG3tet and ECM/TG3tet, measured by the incorpora-
tion of biotinylated cadaverine into FN in culture mediumDMEM in the
absence (DM) or presence of 5 mM DTT (DTT). Data represent the
mean  S.D. of 3 replicates from a typical experiment.
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pendent cell adhesion (5, 8), and the increased externalization
and binding of tTG to the FN matrix in response to wounding
(16, 17) may result in an alternative adhesion-dependent sur-
vival pathway. Non-confluent cultures of mouse dermal fibro-
blasts devoid of tTG (MDF-TG/) were plated on FN or
tTG-FN and incubated with RGD peptide under serum-free
conditions. After 15 h, the majority of the RGD-treated cells
plated on FN were detached and displayed morphological signs
of apoptosis. The extent of endonucleolysis was measured by
fluorescent labeling of DNA strand breaks using TUNEL and
quantified by flow cytometry (Fig. 9A). After incubation with
the RGD peptide 24% of the total fibroblasts grown on FN
were apoptotic (black histogram) compared with only 2.6% of
fibroblasts grown on tTG-FN (blue histogram), which behaved
similarly to control cells grown on FN in the absence of RGD
peptide (green histogram). These data were corroborated by in
situ fluorescent labeling of nuclei undertaken on the detached
cells in suspension, which was visualized and scored by confo-
cal microscopy (Fig. 9B). At 15 h exposure to the RGD peptide,
a significantly lower number of apoptotic cells were found in
the culture fluid of cells grown on tTG-FN compared with FN.
The level of apoptosis upon incubation on tTG-FN was compa-
rable with that found in the culture medium of control cells on
FN without the RGD peptide (Fig. 9B). After 30 h incubation in
the absence of serum, nuclear fragmentation appeared to in-
crease not only in cells grown with RGD peptide but also in
cells grown on FN without RGD peptide, thus limiting our
investigations to 15 h time-period (Fig. 9B). We next assayed
the viability of MDF-TG/ in response to tTG-FN (Fig. 9C).
Cell viability on FN was significantly decreased after 15-h
exposure to RGD peptide, compared with control RAD peptide
(Fig. 9C), in agreement with the level of total apoptotic cell
death measured in the same conditions by flow cytometry (Fig.
9A). In contrast, cell viability on tTG-FN was not substantially
altered by incubation with RGD peptide, and it was found to be
30% higher than on FN (Fig. 9C), indicating that attachment
to tTG-FN mediates RGD-independent cell survival.
DISCUSSION
The impact of tTG, a well characterized FN-associating pro-
tein and modulator of the FN matrix on FN-mediated cell
survival has never been investigated (38). Whereas previous
studies have analyzed the roles of tTG by modulating its ex-
pression (22, 25, 26, 39), in the present study we have devel-
oped a model that allows us to characterize cellular responses
to a tTG-rich FN matrix, thus mimicking physio/pathological
conditions in vivo. Support for our model comes from findings
that tTG is not only externalized under normal physiological
conditions but it is also up-regulated, exported, and deposited
into the ECM in response to tissue trauma following cellular
damage, inflammation, or cell stress (16, 17, 40), where it
either binds FN fibrils directly or plasma FN (20, 22, 24), which
is then deposited in the damaged area. Hence a complex of tTG
and FN, formed as a result of matrix alterations during tissue
injury, may provide a mechanism to ensure adhesion-mediated
cell survival in wound-repair in response to the reduction or
loss of RGD-dependent cell adhesion (8, 5).
To test this hypothesis, we initially examined the function of
the tTG-FN complex in cell-matrix interactions whereby we
inhibited the “classical” adhesion-mediated survival pathway
dependent on the interaction of the FNIII10 RGD cell-binding
site with 51 integrins. A human osteoblast-like cell line
served as the initial cell model because osteoblasts secrete both
FN and tTG (30, 34, 41) are subject to continuous matrix
remodeling processes during their differentiation, are charac-
terized by a well defined and simple pattern of integrin cell
surface receptors, mainly 1, and make use of RGD-independ-
ent pathways in the attachment to the ECM (34). We demon-
strate that the loss of cell-matrix interaction by inhibition of
RGD-dependent integrin function can be largely re-established
FIG. 9. Cell attachment to tTG-FN promotes cell survival of
tTG-null dermal fibroblasts induced to undergo apoptosis by
inhibition of RGD-dependent integrin function. A, flow cytometric
analysis of apoptosis in tTG-null mouse dermal fibroblasts (MDF-TG/
). Cells were seeded in medium containing RGD peptide (100 g/ml) or
DMEM only, on FN or tTG-FN for 15 h. As a measure of apoptosis,
nuclear fragmentation of both adherent and detached cells was detected
by TUNEL and quantified by flow cytometry as described under “Ex-
perimental Procedures.” The bar denotes the positive region of frag-
mented nuclei (% apoptotic nuclei), set by the negative standard (n.s.) of
cells undergoing anoikis and incubated with FITC-dUTP in the absence
of the enzyme TdT (red histogram). Md, median fluorescence channel.
B, In situ analysis of nuclear fragmentation of MDF-TG/. Cells were
treated with RGD peptide and incubated as described in A. After 15 h
and 30 h growth, the fractions of cells in suspension were processed for
in situ detection of DNA fragmentation, which was scored by confocal
fluorescent microscopy as described under “Experimental Procedures.”
Data represent the mean number  S.D. of apoptotic cells/well from a
typical experiment undertaken in triplicate. Total cells analyzed, 450
and 400 at 15 h and 30 h, respectively. Bar  10 M. C, cell viability
assay of MDF-TG/. Cells were grown in medium containing RGD or
control RAD peptide (100 g/ml) on FN or tTG-FN for 15 h, as described
above. Cell viability was tested following incubation of cells with XTT.
Data represent the mean  S.D. of a typical experiment performed in
quadruplicate.
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upon seeding of cells on either FN with associated tTG or a
more physiological matrix of cell-assembled FN containing cell-
secreted tTG. This latter form of tTG-FN matrix is thought to
be the most important form present in vivo as in tissues, FN is
present as an insoluble fibrillar matrix to which tTG is closely
associated (20, 22). Restoration of cell adhesion by tTG-FN
following RGD inhibition was also found in mouse Swiss 3T3
fibroblasts and in the epithelial-like cells ECV-304, suggesting
that many cell types can use the RGD-independent cell-adhe-
sion pathway mediated by tTG-FN.
We demonstrate that cell adhesion to tTG-FN is not linked to
modification of FN by calcium-dependent transamidation. This
finding is consistent with recent observations indicating a
transamidating-independent role for tTG in cell-matrix inter-
actions (19, 27, 28). Moreover we show that when tTG is com-
plexed with FN it becomes catalytically inactive unless kept in
a reduced state. Indeed, previous work has described that tTG
sequestration by FN leads to down-regulation of enzymatic
activity on large-size protein substrates (24). In contrast, in
situ tTG activity demonstrated with small-size fluorescent pri-
mary amine substrate has clearly shown that tTG is catalyti-
cally active while present at the cell surface (22). tTG may
modify FN by its intrinsic protein disulfide isomerase (PDI)
activity, which has been recently ascribed to it (42). However,
because GTP binding to tTG affects the adhesion function of
FN-bound tTG but does not affect the PDI activity of tTG this
possibility seems unlikely.
The outside-in signaling induced by the RGD-independent
cell adhesion to tTG-FN appears to result by direct interaction
of tTG with the cell surface, because the blocking of tTG acces-
sibility by a monoclonal antibody greatly reduces this process.
The calcium-mediated tertiary structure of tTG is also re-
quired, suggesting that crucial cell-binding sites might be ex-
posed when tTG assumes the calcium-induced open conforma-
tion. However, the simple binding of 20 g/ml tTG to either
tissue culture plastic or the gelatin-binding domain of FN,
which contains the tTG-binding site (13), does not enhance cell
adhesion, which is indeed equally negligible regardless of the
presence of tTG, in contrast to what has been previously re-
ported (27, 28). We also found that tTG binding to the 70 kDa
amino-terminal fragment of FN, which can support cell adhe-
sion and includes the tTG-binding site, is not sufficient to
sustain tTG-mediated RGD-independent cell adhesion. This
leads us to conclude that the RGD-independent adhesion to
tTG-FN is both tTG- and FN-dependent, with the amino-ter-
minal of FN required to support tTG binding and the carboxy-
terminal of FN and/or cryptic epitopes outside the FNIII9–10
domains, essential to sustain the RGD-independent pathway.
Our data also suggest that the RGD-independent cell adhe-
sion to tTG-FN is integrin-independent or, alternatively, the
integrin must be in partnership with some other receptor(s).
This observation is supported by the finding that tTG-mediated
focal adhesions still formed in the presence of function blocking
anti-integrin antibodies 1 and 5, which cause conformational
inactivation of the receptor, thus preventing outside in signal-
ing (43). Under these conditions the actin stress fibers formed
appeared less complex than normal, nevertheless the cytoar-
chitecture was sufficient for the formation of distinct RGD-
independent focal adhesions, which are mediated by GTPase
RhoA and induce FAK tyrosine phosphorylation. Therefore,
modulation of matrix FN by tTG adds to the increasing number
of non-integrin-mediated stimuli, which enhance FAK activity
through actin polymerization (44). The possibility that tTG-FN
maymediate RGD-independent cell adhesion through the 41-
induced RGD-independent pathway is also unlikely because
low or negligible levels of 4 subunit are generally expressed in
osteoblasts (34). Moreover, matrix binding to 41 does not
generate actin stress fibers (45). Although tTG association with
integrins is documented, our data suggest that it is more likely
that the cell function induced by tTG-FN results from the
binding to non-integrin receptors. Given the high affinity bind-
ing of tTG for heparin (46), a possible candidate receptor for
tTG-FN is that belonging to the class of HSPG (35). Treatment
of HOB cells with heparitinase but not chondroitinase ABC
greatly diminished the RGD-independent adhesion in response
to tTG-FN, suggesting that cell surface HSPG may mediate
RGD-independent cell adhesion to tTG-FN. The C-terminal
HepII domain of FN is responsible for the synergistic interac-
tion of FN with cell surface heparan sulfate and integrins, and
this interaction is essential for optimal cell adhesion and crit-
ical for sustained cell survival (7, 35). Association of tTG with
FN could induce RGD-independent cell adhesion by reinforcing
HSPG-mediated adhesion, through a dual mechanism involv-
ing the binding of tTG to cell surface HSPG and increased
exposure of the C-terminal heparin-binding domain of FN,
which critically depends on FN structure (9). The increased cell
spreading observed in osteoblasts and Swiss 3T3 fibroblasts in
early cell adhesion to tTG-FN also in the absence of integrin
inhibition suggests that HSPG receptors are not fully occupied
when cells are normally seeded on a FN matrix and that in-
creased binding occurs in response to tTG-FN. Downstream
signaling from syndecan-4, the only HSPG that is a widespread
component of focal adhesion, specifically results in hyperacti-
vation of PKC and activation of both RhoA and FAK (7, 35).
Our results suggest that RGD-independent cell adhesion me-
diated by tTG-FN requires PKC activity because the com-
pound Go¨6976, which is the only inhibitor available that shows
specificity for PKC (36), blocks this process. Our data also
show that the function of FN-bound tTG depends on RhoA
activation and is linked to activation of the cell survival kinase
FAK (1, 44).
Moreover, in preliminary investigations using a Raf-1-null
3T3 like immortalized fibroblast cell line (47) we could demon-
strate that the RGD-independent cell adhesion pathway by
tTG-FN is not functional in this cell line.3 This suggests that
the Raf-1 protein, whose main function is anti-apoptotic (47),
may be a key component in the signaling pathway mediated by
tTG-FN. The observation that a tTG-FN matrix can rescue
tTG-null primary dermal fibroblasts from anoikis with main-
tenance of cell viability is therefore consistent with its activa-
tion of intracellular survival mediators. Importantly, it shows
that the survival role of tTG is essentially extracellular and not
intracellular as recently suggested by Antonyak et al. (48),
following up-regulation of tTG by retinoic acid.
It is now accepted that RGD-mediated cell adhesion is not
sufficient in isolation to maintain cell survival. For sustained
survival cells need to interact with “complex” ECMs via inte-
grin and non-integrin receptors, such as cell surface proteogly-
cans (7). Interestingly like tTG, increased expression of synde-
can-4 is also found at sites of tissue injury (35). The work
presented here indicates that binding of tTG to FN represents
one additional survival signal by inducing heparan-sulfate re-
ceptors-mediated cell adhesion, which can either act in synergy
or in alterative to integrin RGD-dependent cell adhesion at
sites of tissue injury.
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